Announcements Trials
Browse Landscape

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Turcot syndrome 1Stomach Neoplasms 1Lymphatic Metastasis 1

Interventions

Cyclophosphamide 2068Radiotherapy 1990Cisplatin 1857Carboplatin 1560Gemcitabine 1455Paclitaxel 1322Bevacizumab 1321pembrolizumab 1240Docetaxel 1227Oxaliplatin 1184Capecitabine 1179Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 973Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 641Lenalidomide 619Biopsy 595Specimen Handling 570

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × DNA Mismatch Repair × Clear all
NCT07625735 2026-06-04

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

Shanghai Zhongshan Hospital

Not yet recruiting
3,000 enrolled

Turcot syndrome, Lymphatic Metastasis

NCT04232020 2020-10-08

A Retrospective Validations Microsatellite Instability (MSI) Testing v Mismatch Repair (MMR) in Gastric Adenocarcinoma

Royal Cornwall Hospitals Trust

Completed
50 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡